关键信息
-
基因名
FSTL3
- 应用
-
别名
FSTL3；FLRG；Follistatin-related Protein 3
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
O95633
-
表达区间
27-263aa
-
氨基酸序列
MGSG NPAPGGVCWL QQGQEATCSL VLQTDVTRAE CCASGNIDTA WSNLTHPGNK INLLGFLGLV HCLPCKDSCD GVECGPGKAC RMLGGRPRCE CAPDCSGLPA RLQVCGSDGA TYRDECELRA ARCRGHPDLS VMYRGRCRKS CEHVVCPRPQ SCVVDQTGSA HCVVCRAAPC PVPSSPGQEL CGNNNVTYIS SCHMRQATCF LGRSIGVRHA GSCAGTPEEP PGGESAEEEE NFV
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
FSTL3, or Follistatin-like 3, is a member of the Follistatin family of proteins, which play crucial roles in various biological processes, including tissue development, cellular differentiation, and inflammatory responses. Research has shown that FSTL3 is implicated in several pathological conditions, such as obesity, diabetes, and cardiovascular diseases, making it a protein of significant interest in the field of biomedical research. Its involvement in modulating signaling pathways, particularly those related to transforming growth factor-beta (TGF-β) superfamily members, further emphasizes its potential as a therapeutic target. The study of FSTL3 recombinant proteins aims to elucidate its functional mechanisms, interactions with other proteins, and its role in disease states. Understanding the structure and function of FSTL3 can facilitate the development of novel therapies, including those aimed at ameliorating metabolic disorders and inflammatory diseases. Advanced techniques such as recombinant DNA technology and protein purification are employed to produce FSTL3 protein in sufficient quantities for experimental analysis. By characterizing the biochemical properties and biological activities of FSTL3, researchers hope to establish its role as a biomarker for disease progression and treatment response, ultimately contributing to personalized medicine approaches in treating related health issues.
